1d
ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...
Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...
Over the last decade, as the Institute for Clinical and Economic Review (ICER) has estimated the cost-effectiveness of newly approved drugs—and ... much more productive COPD patients can expect ...
The study, involving nearly 394,000 adults, demonstrates that certain diabetes medications may offer unexpected benefits for respiratory health. Global health projections indicate that COPD will ...
However, a doctor will address any underlying causes and may prescribe medications such as furosemide or heparin to reduce fluids in the body. Edema is swelling due to liquid trapped in the body ...
At least 20 workers were abducted in Lama upazila of Bandarban last night. The incident took place near the Goyal Mara Murungjhiri rubber plantation in Phansia Khali union of the upazila. Confirming ...
There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...
Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback